Zimmer Biomet Holdings Statistics
Total Valuation
ZBH has a market cap or net worth of $20.94 billion. The enterprise value is $28.11 billion.
| Market Cap | 20.94B |
| Enterprise Value | 28.11B |
Important Dates
The next estimated earnings date is Wednesday, October 29, 2025, before market open.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | Sep 30, 2025 |
Share Statistics
ZBH has 198.10 million shares outstanding. The number of shares has decreased by -3.63% in one year.
| Current Share Class | 198.10M |
| Shares Outstanding | 198.10M |
| Shares Change (YoY) | -3.63% |
| Shares Change (QoQ) | -0.70% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 98.90% |
| Float | 197.54M |
Valuation Ratios
The trailing PE ratio is 25.73 and the forward PE ratio is 12.72. ZBH's PEG ratio is 2.01.
| PE Ratio | 25.73 |
| Forward PE | 12.72 |
| PS Ratio | 2.69 |
| Forward PS | 2.44 |
| PB Ratio | 1.67 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.90 |
| P/OCF Ratio | 12.59 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.86, with an EV/FCF ratio of 22.69.
| EV / Earnings | 34.13 |
| EV / Sales | 3.59 |
| EV / EBITDA | 10.86 |
| EV / EBIT | 18.16 |
| EV / FCF | 22.69 |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.62.
| Current Ratio | 1.87 |
| Quick Ratio | 0.80 |
| Debt / Equity | 0.62 |
| Debt / EBITDA | 2.91 |
| Debt / FCF | 6.23 |
| Interest Coverage | 5.91 |
Financial Efficiency
Return on equity (ROE) is 6.53% and return on invested capital (ROIC) is 4.96%.
| Return on Equity (ROE) | 6.53% |
| Return on Assets (ROA) | 4.36% |
| Return on Invested Capital (ROIC) | 4.96% |
| Return on Capital Employed (ROCE) | 7.68% |
| Revenue Per Employee | $460,812 |
| Profits Per Employee | $48,441 |
| Employee Count | 17,000 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.93 |
Taxes
In the past 12 months, ZBH has paid $147.60 million in taxes.
| Income Tax | 147.60M |
| Effective Tax Rate | 15.17% |
Stock Price Statistics
The stock price has decreased by -7.64% in the last 52 weeks. The beta is 0.68, so ZBH's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -7.64% |
| 50-Day Moving Average | 98.09 |
| 200-Day Moving Average | 102.07 |
| Relative Strength Index (RSI) | 61.42 |
| Average Volume (20 Days) | 1,344,727 |
Short Selling Information
The latest short interest is 6.96 million, so 3.51% of the outstanding shares have been sold short.
| Short Interest | 6.96M |
| Short Previous Month | 7.34M |
| Short % of Shares Out | 3.51% |
| Short % of Float | 3.52% |
| Short Ratio (days to cover) | 3.84 |
Income Statement
In the last 12 months, ZBH had revenue of $7.83 billion and earned $823.50 million in profits. Earnings per share was $4.11.
| Revenue | 7.83B |
| Gross Profit | 5.58B |
| Operating Income | 1.55B |
| Pretax Income | 1.02B |
| Net Income | 823.50M |
| EBITDA | 2.59B |
| EBIT | 1.55B |
| Earnings Per Share (EPS) | $4.11 |
Balance Sheet
The company has $556.90 million in cash and $7.72 billion in debt, giving a net cash position of -$7.16 billion or -$36.17 per share.
| Cash & Cash Equivalents | 556.90M |
| Total Debt | 7.72B |
| Net Cash | -7.16B |
| Net Cash Per Share | -$36.17 |
| Equity (Book Value) | 12.53B |
| Book Value Per Share | 63.29 |
| Working Capital | 2.35B |
Cash Flow
In the last 12 months, operating cash flow was $1.66 billion and capital expenditures -$424.00 million, giving a free cash flow of $1.24 billion.
| Operating Cash Flow | 1.66B |
| Capital Expenditures | -424.00M |
| Free Cash Flow | 1.24B |
| FCF Per Share | $6.25 |
Margins
Gross margin is 71.25%, with operating and profit margins of 19.76% and 10.51%.
| Gross Margin | 71.25% |
| Operating Margin | 19.76% |
| Pretax Margin | 12.42% |
| Profit Margin | 10.51% |
| EBITDA Margin | 33.04% |
| EBIT Margin | 19.76% |
| FCF Margin | 15.82% |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 0.91%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.91% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.36% |
| Buyback Yield | 3.63% |
| Shareholder Yield | 4.54% |
| Earnings Yield | 3.93% |
| FCF Yield | 5.92% |
Analyst Forecast
The average price target for ZBH is $112.39, which is 6.30% higher than the current price. The consensus rating is "Hold".
| Price Target | $112.39 |
| Price Target Difference | 6.30% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 4.89% |
| EPS Growth Forecast (5Y) | 19.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ZBH has an Altman Z-Score of 2.61 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.61 |
| Piotroski F-Score | 6 |